Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €85.11 EUR
Change Today +2.25 / 2.71%
Volume 495.0
WMD On Other Exchanges
As of 1:53 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David T. Hung M.D.

Founder, Chief Executive Officer, President and Executive Director, Medivation, Inc.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. David T. Hung, M.D. is the Founder of Medivation, Inc. Dr. Hung has been the Chief Executive Officer and President of Medivation, Inc. since December 17, 2004. Dr. Hung served as the Chief Executive Officer and President of Medivation Neurology, Inc., a subsidiary of Medivation, Inc. since September 2003 until December 2004. Dr. Hung co-founded Medivation (NASDAQ: MDVN) in 2003. He served as Consultant and Adviser of Freedom Eye Ltd. since July 13, 2006. From 1998 ...

Read Full Background

Corporate Headquarters*

525 Market Street
San Francisco, California 94105

United States

Phone: 415-543-3470
Fax: 415-543-3411

Board Members Memberships*

Founder, Chief Executive Officer, President and Executive Director


Harvard College
Harvard College
University of California-San Francisco

Other Affiliations*

Annual Compensation*

Total Annual Compensation$787,500

Stock Options*

Restricted Stock Awards$1,914,500
All Other Compensation$13,356
Exercised Options330,000
Exercised Options Value$22,926,056
Exercisable Options1,197,684
Exercisable Options Value$99,436,126
Unexercisable Options277,309
Unexercisable Options Value$10,628,597
Total Value of Options$132,990,778
Total Number of Options1,804,993

Total Compensation*

Total Annual Cash Compensation$2,493,956
Total Short Term Compensation$787,500
Other Long Term Compensation$1,927,856
Total Calculated Compensation$10,570,946
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WMD:GR €85.11 EUR +2.25


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer and President
Ariad Pharmaceuticals Inc.
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics, Inc.
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia, Global Operations, Executive Director, Member of Audit Committee and Member of Corporate Social Responsibility Committee
Sanofi India Limited
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVATION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at